Literature DB >> 9006320

Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.

R Wienecke1, J C Maize, J A Reed, J de Gunzburg, R S Yeung, J E DeClue.   

Abstract

The tuberous sclerosis-2 (TSC2) gene is linked to tuberous sclerosis (TSC), a dominantly inherited genetic syndrome in which inactivation of the normal TSC2 allele is associated with the development of mostly benign tumors and focal dysplasias. TSC2 encodes the protein tuberin, which is a widely expressed 180-kd polypeptide that exhibits specific GTPase activating activity toward Rap1 in vitro and co-localizes with Rap1 in cultured cells. In this study, we have performed immunohistochemical analyses, using affinity-purified anti-tuberin antibodies, to study the distribution of tuberin in a panel of normal human organs that are commonly affected by TSC. Cryosections indicated that tuberin is widely expressed at low levels. More intense staining of tuberin, in the cryosections and in paraffin sections, was observed in the small blood vessels of many organs, including the kidney, skin, and adrenal gland. High levels of tuberin were also detected in cortical neurons and cerebellar Purkinje cells. These findings imply that loss-of-function mutations in TSC2 might lead to the development of highly vascularized tumors, subcortical tubers, and focal atrophy of the cerebellar cortex, which are features commonly associated with TSC. Moreover, Rap1 was also found to be highly expressed in many of the same cells that contained high levels of tuberin, suggesting a functional interaction between tuberin and Rap1 in these tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006320      PMCID: PMC1858502     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Renal involvement in tuberous sclerosis.

Authors:  J Bernstein; T O Robbins
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Cardiac rhabdomyomas in tuberous sclerosis.

Authors:  G H Watson
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 3.  Neurocutaneous syndromes associated with pigmentary skin lesions.

Authors:  A Zvulunov; N B Esterly
Journal:  J Am Acad Dermatol       Date:  1995-06       Impact factor: 11.527

4.  Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes.

Authors:  Y Yoshida; M Kawata; Y Miura; T Musha; T Sasaki; A Kikuchi; Y Takai
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

5.  Refined localization of TSC1 by combined analysis of 9q34 and 16p13 data in 14 tuberous sclerosis families.

Authors:  B Janssen; J Sampson; M van der Est; W Deelen; S Verhoef; I Daniels; A Hesseling; P Brook-Carter; M Nellist; D Lindhout
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

Review 6.  Tuberous sclerosis.

Authors:  D J Kwiatkowski; M P Short
Journal:  Arch Dermatol       Date:  1994-03

7.  Causes of death in patients with tuberous sclerosis.

Authors:  C W Shepherd; M R Gomez; J T Lie; C S Crowson
Journal:  Mayo Clin Proc       Date:  1991-08       Impact factor: 7.616

8.  Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.

Authors:  R Wienecke; A König; J E DeClue
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

9.  Variability of expression in tuberous sclerosis.

Authors:  H Northrup; J W Wheless; T K Bertin; R A Lewis
Journal:  J Med Genet       Date:  1993-01       Impact factor: 6.318

10.  RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts.

Authors:  S J Cook; B Rubinfeld; I Albert; F McCormick
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  10 in total

1.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.

Authors:  E P Henske; L L Wessner; J Golden; B W Scheithauer; A O Vortmeyer; Z Zhuang; A J Klein-Szanto; D J Kwiatkowski; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

2.  Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.

Authors:  R Buscà; P Abbe; F Mantoux; E Aberdam; C Peyssonnaux; A Eychène; J P Ortonne; R Ballotti
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.

Authors:  S K Kim; K C Wang; B K Cho; H W Jung; Y J Lee; Y S Chung; J Y Lee; S H Park; Y M Kim; G Choe; J G Chi
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

Review 4.  Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.

Authors:  Emmett V Schmidt; Michael J Ravitz; Li Chen; Mary Lynch
Journal:  Cell Cycle       Date:  2009-05-18       Impact factor: 4.534

Review 5.  Autism and tuberous sclerosis.

Authors:  S L Smalley
Journal:  J Autism Dev Disord       Date:  1998-10

6.  Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis.

Authors:  Jack L Arbiser; Baskaran Govindarajan; Xianhe Bai; Hiroaki Onda; Andrius Kazlauskas; So Dug Lim; Mahul B Amin; Lena Claesson-Welsh
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

7.  Immunohistochemical detection of receptor-associated protein in normal human brain and Alzheimer's disease.

Authors:  John Provias; Brian Jeynes
Journal:  Patholog Res Int       Date:  2010

8.  Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat.

Authors:  P C Howard; A Warbritton; K A Voss; R J Lorentzen; J D Thurman; R M Kovach; T J Bucci
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 9.  Pediatric cerebral cavernous malformations: Genetics, pathogenesis, and management.

Authors:  Michael G Z Ghali; Visish M Srinivasan; Arvind C Mohan; Jeremy Y Jones; Peter T Kan; Sandi Lam
Journal:  Surg Neurol Int       Date:  2016-12-28

Review 10.  The development of the kidney.

Authors:  J A Davies; J B Bard
Journal:  Curr Top Dev Biol       Date:  1998       Impact factor: 4.897

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.